Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 13133-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#13133-1-AP, RRID:AB_2214691
- Product name
- ULBP2 antibody
- Antibody type
- Polyclonal
- Description
- ULBP2 antibody (Cat. #13133-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references ULBP2 promotes progression of head and neck squamous cell carcinoma by modulating MAPK signaling pathway.
TAK-981 potentiates doxorubicin immunocide in triple-negative breast cancer by IFN I-dependent NK cell stimulation.
ULBP2 CAR-T cells enhance gastric cancer immunotherapy by inhibiting CAF activation.
Pleckstrin-2 promotes tumour immune escape from NK cells by activating the MT1-MMP-MICA signalling axis in gastric cancer.
Venetoclax enhances NK cell killing sensitivity of AML cells through the NKG2D/NKG2DL activation pathway.
CD44 3'-Untranslated Region Functions as a Competing Endogenous RNA to Enhance NK Sensitivity of Liver Cancer Stem Cell by Regulating ULBP2 Expression.
Xu W, Liu S, Yang W
Journal of stomatology, oral and maxillofacial surgery 2025 Jun;126(3S):102204
Journal of stomatology, oral and maxillofacial surgery 2025 Jun;126(3S):102204
TAK-981 potentiates doxorubicin immunocide in triple-negative breast cancer by IFN I-dependent NK cell stimulation.
Liu J, Wang Y, Wei X, Liu S, Hu C, Peng P, Wu W, Cai J, Sun H
Cellular oncology (Dordrecht, Netherlands) 2025 Dec;48(6):1871-1887
Cellular oncology (Dordrecht, Netherlands) 2025 Dec;48(6):1871-1887
ULBP2 CAR-T cells enhance gastric cancer immunotherapy by inhibiting CAF activation.
Zhang W, Ren W, Guo S, Han H, Cai W, Bai H, Li L, Jiang X, Zheng X, Zhang T, Wang Y, Ye H, Cao H, Shi W, Zhou H, Yu Z, Qin L, Jiao Z
Cell death & disease 2025 Aug 8;16(1):597
Cell death & disease 2025 Aug 8;16(1):597
Pleckstrin-2 promotes tumour immune escape from NK cells by activating the MT1-MMP-MICA signalling axis in gastric cancer.
Mao D, Zhou Z, Chen H, Liu X, Li D, Chen X, He Y, Liu M, Zhang C
Cancer letters 2023 Sep 28;572:216351
Cancer letters 2023 Sep 28;572:216351
Venetoclax enhances NK cell killing sensitivity of AML cells through the NKG2D/NKG2DL activation pathway.
Wu HY, Li KX, Pan WY, Guo MQ, Qiu DZ, He YJ, Li YH, Huang YX
International immunopharmacology 2022 Mar;104:108497
International immunopharmacology 2022 Mar;104:108497
CD44 3'-Untranslated Region Functions as a Competing Endogenous RNA to Enhance NK Sensitivity of Liver Cancer Stem Cell by Regulating ULBP2 Expression.
Weng J, Han X, Liu K, Yang J, Wei S, Zhang Y, Zeng F, Li Y, Shen L, Gao Y
International journal of biological sciences 2019;15(8):1664-1675
International journal of biological sciences 2019;15(8):1664-1675
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The ULBP2 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human ULBP2. This antibody recognizes human antigen. The ULBP2 antibody has been validated for the following applications: ELISA, WB analysis.
